NAUT Q4 2020 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$289M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$194,000

Operating Income

-$5M

Net Income

-$5M

EPS (Diluted)

$-0.17

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$250,000

Balance Sheet

Total Assets

$85M

Total Liabilities

$115M

Stockholders' Equity

-$30M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$194,000	$0	—
Operating Income	-$5M	-$355,000	-1398.6%
Net Income	-$5M	$385,490	-1488.4%